ER780 Anti-Human CD3 Antibody[OKT3]

The ER780 Anti-Human CD3 Antibody, also known as OKT3, is a highly effective and reliable immunotherapeutic agent designed to target and neutralize the CD3 antigen present on human T cells. This monoclonal antibody is produced using advanced biotechnological methods, ensuring exceptional purity and potency.

With its exceptional specificity and affinity for CD3, the ER780 Antibody offers a powerful tool for researchers and clinicians in the field of immunology. It enables precise identification and characterization of T cells, facilitating a deeper understanding of their role in immune responses and diseases.

The ER780 Antibody's exceptional binding capacity allows for a wide range of applications, including flow cytometry, immunohistochemistry, and immunoprecipitation. Its versatility makes it an invaluable asset in various research settings, such as cancer immunotherapy, autoimmune disease studies, and transplantation research.

Furthermore, the ER780 Antibody has been extensively tested for safety and efficacy, ensuring its suitability for use in clinical settings. Its consistent performance and reproducibility make it an ideal choice for diagnostic purposes and therapeutic interventions.

In summary, the ER780 Anti-Human CD3 Antibody, also known as OKT3, is a highly reliable and versatile immunotherapeutic agent that offers exceptional specificity and affinity for CD3. With its broad range of applications and proven safety profile, it is an indispensable tool for researchers and clinicians alike in the field of immunology.